Ovarian cancer vaccines are under development, but none are ready for primetime. There are no screening tools for ovarian ...
The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...
Buckhead’s Lenox Square Mall will host the 2024 Teal to Heal Fashion Show Thursday, Nov. 21, from 6:30 p.m. to 9 p.m., featuring ovarian cancer survivors and caregiver models st ...
The EC has approved Elahere for treating adult patients with folate receptor-alpha (FRα) positive, platinum-resistant and ...
Nine years as an ovarian cancer “lifer” yields these tips for surviving and thriving when there’s no end of treatment ahead.
Haas added that J&J's own analysis found an absence of asbestos contamination in its products and said "independent science ...
Bianca Muñiz, a three-time cancer survivor first diagnosed at age 11, shared her powerful story on International Childhood ...
Thousands of women in the UK are planning to take legal action against Johnson & Johnson over alleged links between its baby ...
Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...
A Derbyshire woman is among thousands of people planning a legal battle against one of the world's biggest pharmaceutical ...
THEO-260 is a mechanistically novel oncolytic immunotherapy developed to tackle the stromal rich tumour microenvironment (TME) evident in advanced ovarian cancer and other solid tumours. Suitable for ...